Rapt Therapeutics Inc
(RAPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -42,997 | -36,147 | -29,115 | N/A |
| Depreciation Amortization | 1,330 | 1,237 | 1,384 | N/A |
| Other Working Capital | 4,133 | 784 | -114 | N/A |
| Other Operating Activity | 2,060 | 1,173 | 722 | 0 |
| Operating Cash Flow | $-35,474 | $-32,953 | $-27,123 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -843 | -3,500 | -1,124 | N/A |
| Investing Cash Flow | $-843 | $-3,500 | $-1,124 | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 35,523 | 266 | 246 | N/A |
| Other Financing Activity | 14,379 | 52,468 | 29,856 | 0 |
| Financing Cash Flow | $49,902 | $52,734 | $30,102 | $N/A |
| Beginning Cash Position | 63,798 | 47,517 | 45,662 | N/A |
| End Cash Position | 77,383 | 63,798 | 47,517 | N/A |
| Net Cash Flow | $13,585 | $16,281 | $1,855 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -35,474 | -32,953 | -27,123 | N/A |
| Capital Expenditure | -888 | -3,500 | -1,124 | N/A |
| Free Cash Flow | -36,362 | -36,453 | -28,247 | 0 |